Finch To Wind Down, Seek Value For Pipeline Assets And IP
Executive Summary
Following two workforce cuts in 2022, Finch said it will cut its staff by 95%, halting a Phase III study of lead recurrent C. diff candidate CP101 and seeking to maximize shareholder value.